Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: Enzymological and clinical aspects

Pediatric Blood and Cancer

Volumn 46, Issue 4, 2006, Pages 434-438

  Brouwer, Connie ^a   Vermunt De Koning, Diana G M ^a   Trueworthy, Robert C ^b   Ter Riet, Patricia G J H ^a   Duley, John A ^c   Trijbels, Frans J M ^a   Hoogerbrugge, Peter M ^a,d   Bökkerink, Jos P M ^a,d   Van Wering, Elisabeth R ^d   De Abreu, Ronney A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c GUY S HOSPITAL   (United Kingdom)

^d DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

Author keywords

6 mercaptopurine; Acute lymphoblastic leukemia; Inosine monophosphate dehydrogenase; Purine enzymes

Indexed keywords

ASPARAGINASE; CYTARABINE; DEXAMETHASONE; GUANINE NUCLEOTIDE; INOSINATE DEHYDROGENASE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; CATALYSIS; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; HUMAN; LYMPHOBLAST; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONITORING; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENZYME ACTIVATION; FEMALE; HUMANS; IMP DEHYDROGENASE; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 33644697201     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20452     Document Type: Article

References (18)

1. Jackson RC, Weber G, Morris HP. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 1975;256:331-333.
2. Montero C, Duley JA, Fairbanks LD, et al. Demonstration of induction of erythrocyte inosine monophosphate dehydrogenase acitivity in Ribavirin-treated patients using a high performance liquid chromatography linked method. Clin Chim Acta 1995;238:169-178.
3. Langman LJ, LeGatt DF, Yatscoff RW. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity. Clin Chem 1995;41:295-299.
4. Collart FR, Huberman E. Cloning and sequence analysis of the human and Chinese hamster inosine 5′-monophosphate dehydrogenase cDNAs. J Biol Chem 1988;263:15769-15772.
5. Natsumeda Y, Ohno S, Kawasaki H, et al. Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem 1990;265:5292-5295.
6. Nagai M, Natsumeda Y, Konno Y, et al. Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res 1991;51:3886-3890.
7. Nagai M, Natsumeda Y, Weber G. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemia cells. Cancer Res 1992;52:258-261.
8. Gruber HE, Jansen I, Willis RC, et al. Alterations of inosinate branchpoint enzymes in cultured human lymphoblasts. Biochim Biophys Acta 1985;846:135-144.
9. Weber G, Nakamura H, Natsumeda Y, et al. Regulation of GTP biosynthesis. Adv Enzym Regul 1992;32:57-69.
10. Saccocia PA, Jr., Miech RP. Inosinic acid dehydrogenase in mammalian tissues. Mol Pharmacol 1969;5:26-29.
11. Veerman AJP, Hählen K, Kamps WA, et al. High cure rate with moderately intensive treatment regimen in non-high risk childhood ALL. Results of protocol ALL VI (1984-1988) from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14:911-918.
12. Price GM, Hoffbrand V, Taheri MR, et al. Inosine monophosphate dehydrogenase activity in acute leukemia. Leukemia Res 1987;11:525-528.
13. Becher HJ, Löhr GW. Inosine 5-phosphate dehydrogenase activity in normal and leukemic blood cells. Klin Wochenschr 1979;57:1109-1115.
14. Alanko S, Salmi TT, Pelliniemi TT. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Pediatr Oncol 1995;24:373-378.
15. Arico M, Lanfranchi A, Molinari E, et al. Cell-mediated cytotoxicity in children during and after therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol 1988;5:279-286.
16. De Vaan GA, van Munster PJ, Bakkeren JA. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood. Eur J Pediatr 1982;139:113-117.
17. Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B-lymphocytes and mserum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992;69:1481-1486.
18. Hedstrom L. IMP dehydrogenase: Mechanism of action and inhibition. Curr Med Chem 1999;6:545-560.